Related Experiment Video
Updated: Jan 14, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Comfort matters: evaluating preferences for Non-Invasive diabetes testing over conventional blood tests
Andrew Sastri Dhanoo1,2, Felicia Hill-Briggs3, Seamus Sreenan4
1Faculty of Science and Technology, Department of Life Sciences, The University of the West Indies, Trinidad and Tobago, St. Augustine, USA.
Most participants prefer non-invasive diabetes testing for comfort and better detection. Revising diabetes mellitus (DM) testing protocols can improve patient experience and outcomes.
Area of Science:
- Endocrinology
- Medical Diagnostics
- Patient Experience
Background:
- Diabetes Mellitus (DM) diagnosis and monitoring often involve invasive blood collection.
- Patient comfort is a crucial, yet often overlooked, aspect of healthcare delivery.
- Assessing comfort levels during diagnostic procedures can inform protocol improvements.
Purpose of the Study:
- To evaluate participant comfort during traditional blood-based Diabetes Mellitus (DM) testing versus non-invasive methods.
- To identify personal characteristics influencing distress during DM testing.
- To assess the preference for non-invasive screening methods in diverse populations.
Main Methods:
- A cross-sectional, observational study involving 232 participants.
- Comfort levels assessed using a ten-item Likert scale (Medical Testing Comfort - MTC scale).
- Principal Component Analysis (PCA) used to identify factors influencing comfort during traditional and non-invasive DM testing.
Main Results:
- The Medical Testing Comfort (MTC) scale demonstrated good reliability (Cronbach's alpha = 0.876).
- 84.1% of participants preferred non-invasive testing methods.
- Individuals without prior DM diagnosis were three times less likely to opt for conventional blood tests.
Conclusions:
- Patient comfort is paramount in diabetes care, driving a strong preference for non-invasive testing.
- Implementing non-invasive methods can potentially improve DM detection, management, and overall healthcare experiences.
- Revising current DM testing protocols to incorporate non-invasive options may enhance patient surveillance and outcomes.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...